SubscribeElsewhere on HealthThreads: Stomach cancer | Thyroid cancer | Overactive bladder | Lymphoma |
UPDATE 2-Spectrum gets fast-track status for bladder cancer drug 
Reuters | Tue, Jul 21
July 21 (Reuters) - Spectrum Pharmaceuticals Inc (SPPI.O: Cotización ) said U.S. health regulators granted fast-track designation to apaziquone, its experimental treatment for a kind of bladder cancer.
Try These Related Topics
Related News
The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive ...
Spectrum collaborates with Handok to develop & commercialize apaziquone in S Korea
UPDATE 1-Spectrum inks deal with Korea's Handok for cancer drug
Intravesical Taxotere® Maintenance Therapy May Improve Treatment of ...
Small cap investors take note of good change for (Nasdaq:SPPI) (Nasdaq:VICL ...
Current status of robot-assisted radical cystectomy - Abstract
Top Bloggers
Related Photos
How To: Surgical Tutorial on da Vinci(R) Anterior Pelvic Exenteration
- Jan 13, 2009 Anterior exenteration can be done for invasive cervical cancer, as in this case, or for invasive bladder cancer. Anterior exenteration is typically ...
Tue, Jan 13 | from CNNMoney.com
